Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03622359 · ClinicalTrials.gov registry record · NA
Radiotracer-Based Perfusion Imaging of Patients With Peripheral Arterial Disease
A NA study of Diabetes Mellitus and Peripheral Artery Disease, sponsored by Nationwide Children's Hospital.
- Recruiting
- Registry status
- NA
- Development phase
- 192
- Enrollment target
- 1
- Study location
NCT03622359: Recruiting NA study of Diabetes Mellitus and Peripheral Artery Disease, sponsored by Nationwide Children's Hospital.
NCT03622359 is a NA study of Diabetes Mellitus and Peripheral Artery Disease that is actively recruiting participants, run by Nationwide Children's Hospital. The registered enrollment target is 192 participants, below the 1,866-participant average among 208 other Diabetes Mellitus trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03622359, a NA study of Diabetes Mellitus and Peripheral Artery Disease, is actively recruiting participants, sponsored by Nationwide Children's Hospital.
- RECRUITING
- Registry status
- NA
- Development phase
- 192 participants
- Enrollment target
- 1
- Study location
Study Summary
The aim of this clinical study is to 1) establish a healthy database for nuclear perfusion imaging of the lower extremities and 2) assess the prognostic value of radiotracer-based perfusion imaging for predicting clinical outcomes in patients with peripheral artery disease (PAD) who are undergoing lower extremity revascularization procedures. We hypothesize that radiotracer imaging of the lower extremities will provide a sensitive non-invasive imaging tool for quantifying regional abnormalities in skeletal muscle perfusion and evaluating responses to medical treatment.
Primary Outcome
The percent or absolute change in perfusion from baseline to post-revascularization will be evaluated.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST SPECT/CT perfusion imaging
- DIAGNOSTIC_TEST PET/CT perfusion imaging
Study Locations (1)
Ohio
- Nationwide Children's Hospital - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 192 participants |
| Start Date | 2017-02-17 |
| Est. Completion | 2028-12-31 |
| Phase | NA |
What NCT03622359 shows while recruiting
NCT03622359 is an interventional study that assigns participants to a tested intervention. The registered 192 participants enrollment target is mid-sized for trials with a published cap, below the 1,866-participant average among 208 other Diabetes Mellitus trials with a reported enrollment target (90% lower).
The record links to 3 conditions, with Diabetes Mellitus appearing as the primary indexed condition, and to 2 interventions - of which SPECT/CT perfusion imaging is the first listed.
NCT03622359 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT03622359 about?
NCT03622359 is a clinical study titled "Radiotracer-Based Perfusion Imaging of Patients With Peripheral Arterial Disease". The aim of this clinical study is to 1) establish a healthy database for nuclear perfusion imaging of the lower extremities and 2) assess the prognostic value of radiotracer-based perfusion imaging for predicting clinical outcomes in patients with peripheral artery disease (PAD) who are undergoing l...
What is the current status of trial NCT03622359?
This trial is currently recruiting. It is a NA study. The enrollment target is 192 participants. The study started on 2017-02-17. Estimated completion is 2028-12-31.
What conditions does trial NCT03622359 study?
This clinical trial studies the following conditions: Diabetes Mellitus, Peripheral Artery Disease, Chronic Limb-Threatening Ischemia.
What interventions are being tested in trial NCT03622359?
The interventions under investigation include: SPECT/CT perfusion imaging (DIAGNOSTIC_TEST), PET/CT perfusion imaging (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03622359?
This trial is sponsored by Nationwide Children's Hospital, which has 188 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03622359 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetes Mellitus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03622359's enrollment target sits among peer trials
192 92nd of 208 higher than 117 of 208 other Diabetes Mellitus trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Diabetes Mellitus trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Improving Glycemic Control With Telemedicine and Smart Insulin Pens
RECRUITING · NA
-
Comparing Healthcare Visit Recording and Open Notes to Improve Chronic iLlness Care Experience in Older Adults
RECRUITING · NA
-
Therapeutic Plantar Electrical Stimulation Intervention During Hemodialysis to Improve Balance and Mobility
RECRUITING · NA
-
FAMily-centered WEight Loss for Black Adults (FAM WEL B-ing)
RECRUITING · NA
-
Innovative Multi-Variable Biofeedback for Improving Gait Performance in Individuals With Diabetic Peripheral Neuropathy
RECRUITING · NA
-
Cardiovascular Kidney and Metabolic Health Assessment and Patient Empowerment
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01492972 · 192 participants · Phase 3
Hypo-fractionated Radiation Therapy With or Without Androgen Suppression for Intermediate Risk Prostate Cancer
- NCT01973881 · 192 participants
Quantitative MRI for Myelofibrosis
- NCT02535702 · 192 participants · NA
Development Of Neuroimaging Methods To Assess The Neurobiology Of Addiction
- NCT05079399 · 192 participants
Biomarker of Diabetic Retinopathy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI